ProstaLund shall offer patients with benign prostate enlargement an individually adapted, non-surgical treatment that is potent, safe and cost effective.

ProstaLund has built up and maintains close links with key figures and institutions in the world of urology. Through exhibitions and conferences, symposiums and clinical studies, the company has succeeded in creating working relationships with leading urologists around the world. These contacts create a solid basis for the acceptance of the company’s products.

PLFT is a simple, inexpensive and safe alternative to traditional surgical (TURP) and drug treatment of BPH. PLFT offers a unique, sophisticated advance in microwave therapy. Constant temperature monitoring throughout the treatment enables the urologist to optimize microwave power according to the patient’s individual condition and responses.

ProstaLund
aim is to improve the quality of life for BPH sufferers by opening up new, individualized treatment options.

ProstaLund is a Swedish-based company situated in an expanding region, close to leading Medtech companies, advanced pharmaceutical industries and Lund University.

The company has its own highly qualified R&D department, and strong international co-operations with leading universities and hospitals. ProstaLund is represented and distributed throughout the world.

ProstaLund product field is concentrated in the Microwave Treatment for PBH by providing the PLFT/CoreTherm which is a new, more patient-friendly method for treating BPH.

ProstaLund CoreTherm